Evaluation and CPD Certificate - Cushing’s Syndrome Demystified: Testing, Treatment, and Risk Reduction

Evaluation

This survey should take approximately 5 minutes to complete.

Question Title

* 1. Please rate the overall learning objectives of this session.
I am able to:

	1 - Strongly Disagree	2 - Somewhat Disagree	3 - Neutral	4 - Somewhat Agree	5 - Strongly Agree
Apply biochemical testing principles to diagnose Cushing’s Syndrome, recognizing sequence and limitations.	Apply biochemical testing principles to diagnose Cushing’s Syndrome, recognizing sequence and limitations. 1 - Strongly Disagree	Apply biochemical testing principles to diagnose Cushing’s Syndrome, recognizing sequence and limitations. 2 - Somewhat Disagree	Apply biochemical testing principles to diagnose Cushing’s Syndrome, recognizing sequence and limitations. 3 - Neutral	Apply biochemical testing principles to diagnose Cushing’s Syndrome, recognizing sequence and limitations. 4 - Somewhat Agree	Apply biochemical testing principles to diagnose Cushing’s Syndrome, recognizing sequence and limitations. 5 - Strongly Agree
Review different medical treatment options and apply them to specific patient scenarios.	Review different medical treatment options and apply them to specific patient scenarios. 1 - Strongly Disagree	Review different medical treatment options and apply them to specific patient scenarios. 2 - Somewhat Disagree	Review different medical treatment options and apply them to specific patient scenarios. 3 - Neutral	Review different medical treatment options and apply them to specific patient scenarios. 4 - Somewhat Agree	Review different medical treatment options and apply them to specific patient scenarios. 5 - Strongly Agree
Identify patients at high risk for acute complications and implement recent recommendations for prophylaxis.	Identify patients at high risk for acute complications and implement recent recommendations for prophylaxis. 1 - Strongly Disagree	Identify patients at high risk for acute complications and implement recent recommendations for prophylaxis. 2 - Somewhat Disagree	Identify patients at high risk for acute complications and implement recent recommendations for prophylaxis. 3 - Neutral	Identify patients at high risk for acute complications and implement recent recommendations for prophylaxis. 4 - Somewhat Agree	Identify patients at high risk for acute complications and implement recent recommendations for prophylaxis. 5 - Strongly Agree

Comments

Question Title

* 2. Please provide feedback on our speakers:

	Dr. Matthieu St-Jean	Dr. Luciana Martel-Duguech	Dr. Jonathan Poirier	Dr. Brandon Galm
The speaker presented information clearly.	The speaker presented information clearly. Dr. Matthieu St-Jean menu	The speaker presented information clearly. Dr. Luciana Martel-Duguech menu	The speaker presented information clearly. Dr. Jonathan Poirier menu	The speaker presented information clearly. Dr. Brandon Galm menu
The speaker was engaging and knowledgeable.	The speaker was engaging and knowledgeable. Dr. Matthieu St-Jean menu	The speaker was engaging and knowledgeable. Dr. Luciana Martel-Duguech menu	The speaker was engaging and knowledgeable. Dr. Jonathan Poirier menu	The speaker was engaging and knowledgeable. Dr. Brandon Galm menu
The speaker managed time effectively.	The speaker managed time effectively. Dr. Matthieu St-Jean menu	The speaker managed time effectively. Dr. Luciana Martel-Duguech menu	The speaker managed time effectively. Dr. Jonathan Poirier menu	The speaker managed time effectively. Dr. Brandon Galm menu
The speaker was credible and non-biased.	The speaker was credible and non-biased. Dr. Matthieu St-Jean menu	The speaker was credible and non-biased. Dr. Luciana Martel-Duguech menu	The speaker was credible and non-biased. Dr. Jonathan Poirier menu	The speaker was credible and non-biased. Dr. Brandon Galm menu
The speaker's slides were clear and concise.	The speaker's slides were clear and concise. Dr. Matthieu St-Jean menu	The speaker's slides were clear and concise. Dr. Luciana Martel-Duguech menu	The speaker's slides were clear and concise. Dr. Jonathan Poirier menu	The speaker's slides were clear and concise. Dr. Brandon Galm menu

Question Title

* 3. Were you able to identify any CanMEDS roles other than Medical Expert in the session? Check all that apply.

Communicator

Collaborator

Leader

Health Advocate

Scholar

Professional

None of the above

Question Title

* 4. As a result of attending this talk, list 3 things you will do differently that you were not doing before.

#1:

#2:

#3:

Question Title

* 5. Please rate your overall experience of Cushing’s Syndrome Demystified:
Testing, Treatment, and Risk Reduction

	1 - Strongly Disagree	2 - Somewhat Disagree	3 - Neutral	4 - Somewhat Agree	5 - Strongly Agree
The content was pertinent to my practice.	The content was pertinent to my practice. 1 - Strongly Disagree	The content was pertinent to my practice. 2 - Somewhat Disagree	The content was pertinent to my practice. 3 - Neutral	The content was pertinent to my practice. 4 - Somewhat Agree	The content was pertinent to my practice. 5 - Strongly Agree
There was adequate time for questions & interaction.	There was adequate time for questions & interaction. 1 - Strongly Disagree	There was adequate time for questions & interaction. 2 - Somewhat Disagree	There was adequate time for questions & interaction. 3 - Neutral	There was adequate time for questions & interaction. 4 - Somewhat Agree	There was adequate time for questions & interaction. 5 - Strongly Agree
Potential conflicts of interest were divulged.	Potential conflicts of interest were divulged. 1 - Strongly Disagree	Potential conflicts of interest were divulged. 2 - Somewhat Disagree	Potential conflicts of interest were divulged. 3 - Neutral	Potential conflicts of interest were divulged. 4 - Somewhat Agree	Potential conflicts of interest were divulged. 5 - Strongly Agree
Generic names were used consistently.	Generic names were used consistently. 1 - Strongly Disagree	Generic names were used consistently. 2 - Somewhat Disagree	Generic names were used consistently. 3 - Neutral	Generic names were used consistently. 4 - Somewhat Agree	Generic names were used consistently. 5 - Strongly Agree
I did not perceive any commercial bias.	I did not perceive any commercial bias. 1 - Strongly Disagree	I did not perceive any commercial bias. 2 - Somewhat Disagree	I did not perceive any commercial bias. 3 - Neutral	I did not perceive any commercial bias. 4 - Somewhat Agree	I did not perceive any commercial bias. 5 - Strongly Agree

Comments

Question Title

* 6. What elements did you like about the session?

Question Title

* 7. What elements did you dislike about the session?

Question Title

* 8. Please share other topic suggestions or learning needs for future sessions.

Please click "Submit" button to access Certificate of Attendance on the next page.

Question Title

* 1. Please rate the overall learning objectives of this session.I am able to:

Question Title

* 2. Please provide feedback on our speakers:

Question Title

* 3. Were you able to identify any CanMEDS roles other than Medical Expert in the session? Check all that apply.

Question Title

* 4. As a result of attending this talk, list 3 things you will do differently that you were not doing before.

Question Title

* 5. Please rate your overall experience of Cushing’s Syndrome Demystified: Testing, Treatment, and Risk Reduction

Question Title

* 6. What elements did you like about the session?

Question Title

* 7. What elements did you dislike about the session?

Question Title

* 8. Please share other topic suggestions or learning needs for future sessions.

* 1. Please rate the overall learning objectives of this session.
I am able to:

* 5. Please rate your overall experience of Cushing’s Syndrome Demystified:
Testing, Treatment, and Risk Reduction